logo

For the Inventor, By the Inventor

Cambridge, MA, United States of America

Francis Lee

This inventor holds 13 USPTO granted patents and 14 published patent applications and 1 EPO patent. Top assignee: Peptilogics, Inc.. Active years: 2021-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Francis Lee. Retrieved from https://idiyas.com/inventor/francis-lee-bav0v1zb

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 13 

% Patents Active = 92.3

 

Average Co-Inventor Count = 3.0

ph-index = 3

Forward Citations = 44(Granted Patents)


Company Filing History:

goldMedal13 out of 13 
 
Peptilogics, Inc.
 patents

Years Active: 2021-2026

Loading Chart...
Loading Chart...
13 patents (USPTO):Explore Patents
1. 12614613 - Generating enhanced graphical user interfaces for presentation of anti-infective design spaces for selecting drug candidates (2026-04-28),
2. 12462902 - Artificial intelligence engine architecture for generating candidate drugs (2025-11-04),
3. 12087404 - Generating anti-infective design spaces for selecting drug candidates (2024-09-10),
4. 12006541 - Methods and apparatuses for generating peptides by synthesizing a portion of a design space to identify peptides having non-canonical amino acids (2024-06-11),
5. 11967400 - Generating enhanced graphical user interfaces for presentation of anti-infective design spaces for selecting drug candidates (2024-04-23),
6. 11848076 - Generating enhanced graphical user interfaces for presentation of anti-infective design spaces for selecting drug candidates (2023-12-19),
7. 11587643 - Methods and apparatuses for a unified artificial intelligence platform to synthesize diverse sets of peptides and peptidomimetics (2023-02-21),
8. 11512345 - Methods and apparatuses for generating peptides by synthesizing a portion of a design space to identify peptides having non-canonical amino acids (2022-11-29),
9. 11462304 - Artificial intelligence engine architecture for generating candidate drugs (2022-10-04),
10. 11436246 - Generating enhanced graphical user interfaces for presentation of anti-infective design spaces for selecting drug candidates (2022-09-06),
11. 11424008 - Generating anti-infective design spaces for selecting drug candidates (2022-08-23),
12. 11403316 - Generating enhanced graphical user interfaces for presentation of anti-infective design spaces for selecting drug candidates (2022-08-02),
13. 11049590 - Artificial intelligence engine architecture for generating candidate drugs (2021-06-29),

Title: The Innovative Journey of Francis Lee

Introduction: Francis Lee, a distinguished inventor based in Cambridge, MA, has made significant contributions to the field of technology through his groundbreaking inventions and patents.

Latest Patents: Francis Lee holds several patents in the areas of artificial intelligence, renewable energy, and biotechnology, showcasing his versatility and forward-thinking approach to innovation.

Career Highlights: With a background in engineering and a passion for problem-solving, Francis Lee has successfully developed cutting-edge solutions that have revolutionized various industries. His commitment to pushing the boundaries of technology is evident in the impact of his inventions.

Collaborations: Throughout his career, Francis Lee has collaborated with leading research institutions, universities, and tech companies to further his innovative projects. His ability to work effectively in multidisciplinary teams has been instrumental in bringing his ideas to life.

Conclusion: Francis Lee's dedication to innovation and his relentless pursuit of excellence have established him as a prominent figure in the world of inventors. His pioneering spirit continues to inspire the next generation of innovators to push the boundaries of what is possible.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…